The company is a wholly owned subsidiary of Showa Denko Materials Co., Ltd.
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products.
Creating Future Cell Therapy Miracles Together
Derived from the Japanese word “mirai” meaning future, and the English word “miracle”, meaning “an extraordinary event”, our new name speaks to our goal to exceed the expectations of our customers.
